Tobramycin and Beta-Lactam Antibiotic Use in Cystic Fibrosis Exacerbations: A Pharmacist Approach.

Zobell, Jeffery T; Epps, Kevin; Kittell, Frederick; Sema, Clarissa; McDade, Erin J; Peters, Stacy J; Duval, Mariela A; Pettit, Rebecca S

Zobell, Jeffery T; Epps, Kevin; Kittell, Frederick; Sema, Clarissa; McDade, Erin J; Peters, Stacy J; Duval, Mariela A; Pettit, Rebecca S.

Afiliação

Zobell JT; Intermountain Primary Children's Hospital, Salt Lake City, Utah.
Epps K; St. Vincent's Hospital Riverside, Jacksonville, Florida.
Kittell F; University of Wisconsin Hospital, Madison, Wisconsin.
Sema C; University of Arizona, Tucson, Arizona.
McDade EJ; Texas Children's Hospital, Houston, Texas.
Peters SJ; Sanford Medical Center, Sioux Falls, South Dakota.
Duval MA; Children's Healthcare of Atlanta, Atlanta, Georgia.
Pettit RS; Riley Hospital for Children at Indiana University Health, Indianapolis, Indiana.

J Pediatr Pharmacol Ther ; 21(3): 239-46, 2016.

Article em En | MEDLINE | ID: mdl-27453702

Palavras-chave

aminoglycosides; antibiotics; antipseudomonal; beta-lactam; cystic fibrosis; extended-interval dosage; pediatrics; pharmacokinetics; pulmonary exacerbations; survey; tobramycin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article